• Home
  • MF Research
  • Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Regular Plan - IDCW Option

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Regular Plan - IDCW Option

arrow-down
NAV
₹ 19.0474 ₹ -0.08 (-0.41 %)
as on 18-06-2025
Asset Size (AUM)
156.35 Cr
Launch Date
Oct 26, 2020
Investment Objective
The Scheme will invest in stocks comprising of the MSCI India Domestic IMI and World Healthcare Select Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be realized and the Scheme does not assure or guarantee any returns.
Minimum Investment 100.0
Minimum Top-up 100.0
Investment Returns Since Launch in Oct 26, 2020
arrow-up

14.96

%
3 M
6 M
1 Y
3 Y
10 Y
Inception
Sharp Ratio
0.55 %
Expense Ratio
1.05%
Volatility
13.18 %
Fund House
Edelweiss Mutual Fund
Fund Manager
Co-Manage
Key Features
Scheme description
Minimum Purchase Application Amount
Rs. 100.0 (plus in multiples of Rs. 100.0)

Entry Load
Not applicable
Exit Load
Yes
Indicative Investment Horizon
5 Years and above
Asset Allocation
Fund's historical return comparison with other asset classes
Created with Highcharts 4.1.4AssetsCash & Cash EquivalentsEquityDerivativesInternational
Fund Performance
Fund's historical return comparison with other asset classes
Created with Highcharts 4.1.4FundFD
Fund₹ 10662
FD₹ 10600
Performance

Scheme Performance (%)

Data as on - 20-06-2025
Created with Highcharts 4.1.4ReturnsEdelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Regular Plan - IDCW OptionMSCI ACWI TRIIndex FundYTD1 Month3 Month6 Month1 Year3 Years5 Years10 YearsSince Launch-100102030

Yearly Performance (%)

Created with Highcharts 4.1.4ValuesEdelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Regular Plan - IDCW OptionMSCI ACWI TRIIndex Fund2016201720182019202020212022202320242025-10010203040
Investment Returns Calculator
Amount InvestedFund ValueProfitReturns
Fund120,000119,620-380-0.69
Benchmark120,000127,8427,84214.59
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Peer Comparison
Scheme Name Inception Date 1 Year Return % 2 Year Return % 3 Year Return % 5 Year Return % 10 Year Return %
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Regular Plan - IDCW Option 26-10-2020 6.62 20.74 20.3 0.0 0.0
Kotak Nifty Financial Services Ex-Bank Index Fund - Regular Plan - Growth option 14-08-2023 21.47 0.0 0.0 0.0 0.0
Tata Nifty MidSmall Healthcare Index Fund - Regular Plan - Growth 26-04-2024 15.79 0.0 0.0 0.0 0.0
Tata Nifty Financial Services Index Fund - Regular Plan - Growth 01-04-2024 14.57 0.0 0.0 0.0 0.0
Motilal Oswal BSE Financials ex Bank 30 Index Fund Regular Growth 29-07-2022 13.54 22.83 0.0 0.0 0.0
Portfolio Analysis
Portfolio as on 31-05-2025
Sector Allocation
SectorAllocation (%)
Healthcare71.63
N/A28.37
Portfolio Holdings
CompanyHoldings (%)
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-12.29
MAX HEALTHCARE INSTITUTE LIMITED EQ6.68
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-6.03
CIPLA LIMITED EQ NEW FV RS.2/-5.87
Dr. Reddys Laboratories Ltd5.58
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/-5.29
ELI LILLY & CO4.86
LUPIN LIMITED EQ NEW F.V. RS.2/-3.41
JOHNSON & JOHNSON3.05
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/-2.87
ABBVIE INC2.68
FORTIS HEALTHCARE LIMITED. EQ2.65
MANKIND PHARMA LIMITED EQ NEW FV RE. 1/-2.33
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-2.29
Novo Nordisk A/S1.88
ABBOTT LABORATORIES1.87
NOVARTIS AG1.86
ZYDUS LIFESCIENCES LIMITED EQ NEW FV RE. 1/-1.79
LAURUS LABS LIMITED EQ NEW FV RS. 2/-1.63
ALKEM LABORATORIES LIMITED EQ1.63
INTUITIVE SURGICAL INC1.61
MERCK & CO.INC1.59
GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/-1.57
IPCA LABORATORIES LIMITED EQ NEW FV RE .1/-1.52
THERMO FISHER SCIENTIFIC INC1.26
AMGEN INC1.26
GILEAD SCIENCES INC1.1
STRYKER CORP1.07
GLAXOSMITHKLINE PHARMACEUTICALS LTD EQ1.07
BIOCON LIMITED EQ1.07
DANAHER CORP1.01
NARAYANA HRUDAYALAYA LIMITED EQ0.95
PIRAMAL PHARMA LIMITED EQ0.94
VERTEX PHARMACEUTICALS INC0.93
GLAND PHARMA LIMITED EQ NEW FV Re.1/-0.9
SYNGENE INTERNATIONAL LIMITED EQ0.89
MEDTRONIC PLC0.87
AJANTA PHARMA LIMITED EQ NEW FV RS. 2/-0.84
SUVEN PHARMACEUTICALS LIMITED EQ0.81
GLOBAL HEALTH LIMITED EQ0.73
Regeneron Pharmaceuticals Inc0.43
BECTON DICKINSON AND CO0.41
AGILENT TECHNOLOGIES INC0.26
IQVIA HOLDINGS INC0.21
Clearing Corporation of India Ltd.0.12
Clearing Corporation of India Ltd.0.12
ILLUMINA INC0.11
Net Receivables/(Payables)-0.07
Net Receivables/(Payables)-0.07
Sector Allocation
Created with Highcharts 4.1.4Others
Portfolio Holdings
Created with Highcharts 4.1.4SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-MAX HEALTHCARE INSTITUTE LIMITED EQDIVIS LABORATORIES LIMITED EQ NEW RS. 2/-CIPLA LIMITED EQ NEW FV RS.2/-Dr. Reddys Laboratories LtdAPOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/-ELI LILLY & COLUPIN LIMITED EQ NEW F.V. RS.2/-JOHNSON & JOHNSONOthers